Literature DB >> 30776966

A comparative protein analysis of lung cancer, along with three controls using a multidimensional proteomic approach.

Mahwish Saleem1,2, Syed K Raza3, Syed G Musharraf1.   

Abstract

IMPACT STATEMENT: A multistep proteomics fractionation strategy was developed and validated for the discovery of proteomic biomarkers which could be used as potential diagnostic biomarkers for monitoring the progression of disease in smokers and COPD patients towards lung cancer.

Entities:  

Keywords:  Lung cancer; MALDI-TOF mass spectrometry; two-dimensional gel electrophoresis

Mesh：

Substances：

Year:  2019        PMID： 30776966      PMCID： PMC6362530          DOI： 10.1177/1535370219826525

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


  21 in total

1.  Evaluation and improving the success rate of protein identification by peptide mass fingerprinting using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Freek Bouwman; Dennis Suylen; Johan Renes; Edwin Mariman
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

2.  Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma.

Authors:  Lynn A Echan; Hsin-Yao Tang; Nadeem Ali-Khan; KiBeom Lee; David W Speicher
Journal:  Proteomics       Date:  2005-08       Impact factor: 3.984

3.  HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.

Authors:  Alex J Rai; Craig A Gelfand; Bruce C Haywood; David J Warunek; Jizu Yi; Mark D Schuchard; Richard J Mehigh; Steven L Cockrill; Graham B I Scott; Harald Tammen; Peter Schulz-Knappe; David W Speicher; Frank Vitzthum; Brian B Haab; Gerard Siest; Daniel W Chan
Journal:  Proteomics       Date:  2005-08       Impact factor: 3.984

4.  Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients.

Authors:  Carla Mendes Maciel; Magno Junqueira; Marcos Eduardo Machado Paschoal; Marcia Tie Kawamura; Ricardo Luiz Menezes Duarte; Maria da Glória da Costa Carvalho; Gilberto Barbosa Domont
Journal:  J Exp Ther Oncol       Date:  2005

5.  Proteomic methodological recommendations for studies involving human plasma, platelets, and peripheral blood mononuclear cells.

Authors:  Baukje de Roos; Susan J Duthie; Abigael C J Polley; Francis Mulholland; Freek G Bouwman; Carolin Heim; Garry J Rucklidge; Ian T Johnson; Edwin C Mariman; Hannelore Daniel; Ruan M Elliott
Journal:  J Proteome Res       Date:  2008-05-20       Impact factor: 4.466

Review 6.  Tumor markers in detection of lung cancer.

Authors:  Joachim Schneider
Journal:  Adv Clin Chem       Date:  2006       Impact factor: 5.394

7.  Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

Authors:  M Patricia Rivera; Atul C Mehta
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

8.  Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease.

Authors:  Morihito Okada; Wataru Nishio; Toshihiko Sakamoto; Kazuya Uchino; Tsuyoshi Yuki; Akio Nakagawa; Noriaki Tsubota
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

9.  The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells.

Authors:  Elaine M Langenfeld; Steve E Calvano; Fadi Abou-Nukta; Stephen F Lowry; Peter Amenta; John Langenfeld
Journal:  Carcinogenesis       Date:  2003-06-19       Impact factor: 4.944

10.  Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).

Authors:  Domenico Ferrigno; Gianfranco Buccheri; Cristina Giordano
Journal:  Lung Cancer       Date:  2003-09       Impact factor: 5.705
View more
  1 in total

1.  Application of two-dimensional difference gel electrophoresis to identify protein changes between center, margin, and adjacent non-tumor tissues obtained from non-small-cell lung cancer with adenocarcinoma or squamous cell carcinoma subtype.

Authors:  Andrzej Ciereszko; Mariola A Dietrich; Mariola Słowińska; Joanna Nynca; Michał Ciborowski; Monika M Kaczmarek; Kamil Myszczyński; Joanna Kiśluk; Anna Majewska; Anna Michalska-Falkowska; Natalia Kodzik; Joanna Reszeć; Ewa Sierko; Jacek Nikliński
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.752
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.